Notably, the E17K activating mutation, located in the PH domain of AKT1, is a hotspot mutation in the Chinese breast cancer population, with a carrier rate of 3.1% [32], and accounting for 90.9% of all AKT1 mutations in luminal A subtypes [28]. Here, AKT1 is linked to breast carcinoma.